Help us to promote this site! Link to us
Email This Page to Friend

Health News BMI Calculator Allergy Alzheimer's Anxiety Arthritis Asthma Back Pain Breast Cancer
Cancer Colon Cancer Depression Diabetes Heart Health HIV/AIDS Lung Cancer Men's Health Mesothelioma
Nutrition Osteoporosis Pregnancy Skin & Beauty Skin Cancer Women's Health Yoga  
Cancer News
Iressa as Good as Chemotherapy for Lung Cancer (HealthDay)
21 Nov 2008 at 10:48pm
HealthDay - FRIDAY, Nov. 21 (HealthDay News) -- The cancer-fighting pill Iressa works as well as chemotherapy as a second-line treatment for lung cancer, researchers report.

ADHD Medications Don't Pose Cancer Risk (HealthDay)
21 Nov 2008 at 10:48pm
HealthDay - FRIDAY, Nov. 21 (HealthDay News) -- Two popular medications for treating attention-deficit hyperactivity disorder (ADHD) do not cause genetic damage linked to an increased risk for developing cancer, a new study says.

New Approach Keeps Tumor Cells From Refueling (HealthDay)
21 Nov 2008 at 10:48pm
HealthDay - FRIDAY, Nov. 21 (HealthDay News) -- Belgian researchers have discovered that some cancer cells use lactic acid instead of sugar for food, and this might lead to new treatments that starve and kill these cells.

Latin Women More Likely to Be Unhappy With Breast Cancer Treatment Decisions...
21 Nov 2008 at 10:48pm
HealthDay - FRIDAY, Nov. 21 (HealthDay News) -- Latina women are almost six times more likely than white women to report great dissatisfaction and regret about their choice of breast cancer treatment, a new report says.

Saturated fat tied to small intestine cancers (Reuters)
21 Nov 2008 at 5:10pm
Reuters - Diets high in saturated fat appear to increase the risk of cancer of the small intestine, a study shows.

Smokeout '08: The Perfect Time to Quit (HealthDay)
20 Nov 2008 at 10:49pm
HealthDay - WEDNESDAY, Nov. 19 (HealthDay News) -- Everyone knows smoking is bad for you. Really bad.

Colorectal Cancer Treatment Costs Vary Widely (HealthDay)
20 Nov 2008 at 10:49pm
HealthDay - THURSDAY, Nov. 20 (HealthDay News) -- The cost of treating colorectal cancer can vary by tens of thousands of dollars per patient.

Inhibiting Protein May Keep Cancer Cells From Refueling (HealthDay)
20 Nov 2008 at 10:49pm
HealthDay - THURSDAY, Nov. 20 (HealthDay News) -- New research on mice suggests inhibiting a protein that allows certain tumor cells to refuel may prove to be key to cancer-fighting treatments.

Colorectal Cancer Screens Detect Unrecognized Disease (HealthDay)
20 Nov 2008 at 10:49pm
HealthDay - THURSDAY, Nov. 20 (HealthDay News) -- Colorectal cancer screening detects 40 percent of cancers and should be carefully planned to be more effective, say Finnish Cancer Registry researchers.

Pill as good as chemo on lung cancer, but costlier (AP)
20 Nov 2008 at 6:51pm
AP - Some advanced lung cancer patients already treated with chemotherapy might be able to skip some of the bad side effects of another series of chemo by taking a pill instead, a study suggests. An international study showed patients on Iressa, an expensive, newer targeted treatment, survived about as long as those on another course of chemotherapy.

ImClone Systems' State-of-the-Art Manufacturing Facility Receives FDA ...
22 Nov 2008 at 2:26am

Nov 20, 2008 - ImClone Systems Incorporated , a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that it has received approval from the Food and Drug ...



Silent Killer: Ex-Miss Maryland urges Fda to intensify skin cancer fight
21 Nov 2008 at 9:56pm

WASHINGTON - Brittany Lietz, Miss Maryland 2006, first used tanning beds when she was 17 and getting ready for the prom; just three years later she was diagnosed with melanoma.



Colorectal Cancer Treatment Costs Vary Widely
21 Nov 2008 at 5:31pm

The cost of treating colorectal cancer can vary by tens of thousands of dollars per patient.



Treating cancer with the power of music
21 Nov 2008 at 1:03pm

Originally posted on: Thursday, November 20, 2008 by Craig Wolf Last updated on: 11/20/2008 6:07:29 PM FORT MYERS: Southwest Florida children who undergo hours of chemotherapy now have inspiration from a world ...



Survival Of Head And Neck Cancer Patients Is Greatly Affected By Coexisting A...
21 Nov 2008 at 8:48am

Main Category: Ear, Nose and Throat Also Included In: Cancer / Oncology Article Date: 20 Nov 2008 Current estimates for head and neck cancer survival are largely inaccurate because they widely disregard many of ...



Breast Cancer Drug Raises Blood Clot Risk, Should Have 'Black Box' Warning, J...
21 Nov 2008 at 4:22am

Genentech 's cancer drug Avastin -- which FDA approved in February for treatment of advanced breast cancer -- increases a patient's risk of developing blood clots in veins, a condition known as venous ...



The reason our stiff upper lip could be fatal
21 Nov 2008 at 12:04am

The British stiff upper lip could account for the country's poor showing in the European cancer survival league but no one knows for sure, the Government's cancer tsar has warned.



Cancer Drugs May Treat Type 1 Diabetes
20 Nov 2008 at 7:41pm

Gleevec, a wonder drug that effectively treats leukemia and other cancers, may also reverse type 1 diabetes, University of California San Francisco, researchers report.



Randomized Phase 2 Study of IMC-A12 for HER2-Expressing Advanced...
20 Nov 2008 at 3:04pm

ImClone Systems Incorporated , a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that its disease-directed randomized Phase 2 clinical trial of ...



Higher Risk Of Certain Cancers Recorded In HIV-Positive People
20 Nov 2008 at 10:36am

Physicians in the U.S. are reporting a higher risk for certain types of cancers -- such as liver, head, neck and lung -- in people living with HIV/AIDS, raising concerns that a cancer epidemic is imminent in ...



Study identifies causes of bone loss in breast cancer survivors
20 Nov 2008 at 6:09am

Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss.



Breast Cancer Eliminating Compounds Show Promise
20 Nov 2008 at 1:58am

Two new compounds created by a University of Central Florida professor show early promise for destroying breast cancer tumors.



Cancer Drug Avastin Raises Blood Clot Risk
19 Nov 2008 at 9:30pm

Nov. 18, 2008 -- The life-extending cancer drug Avastin raises the risk of dangerous blood clots by 33%, an analysis of clinical-trial data shows.



New platinum-phosphate compounds kill ovarian cancer cells
19 Nov 2008 at 5:11pm

A new class of compounds called phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than conventional drugs, according to a new study published ...



Cancer Society sunscreens to allow margin of error
19 Nov 2008 at 12:45pm

The Commerce Commission says a long-running row over some suncreens falling short of their claimed SPF ratings stems from variations between tests and laboratories.



Cancer survival affects online support
22 Nov 2008 at 1:23am
Posted on: Saturday, 22 November 2008, 00:17 CST Online support sites for high survival rate cancers have more emotional support content than sites for low survival rate cancers, U.S. researchers s...

Bone loss due to more than cancer drugs
22 Nov 2008 at 1:23am
Posted on: Friday, 21 November 2008, 22:58 CST Certain cancer drugs can cause bone loss in breast cancer survivors, but cancer drugs aren't the only culprits, U.S. researchers said. The study, pub...

Colorectal cancer screening
22 Nov 2008 at 1:23am
Posted on: Friday, 21 November 2008, 20:15 CST Roughly four out of 10 colorectal cancers were detected in Finland by a colorectal cancer screening program using a fecal occult blood test, researche...

Police, Firefighters Aim To Defeat Cancer
22 Nov 2008 at 12:56am
Wharton High School to watch Tampa police officers and firefighters face off in the Badge Bowl, a fundraising flag-football game that each year benefits a child with cancer. Organizers chose to featu...

Post To Host Benefit For 2-Year-Old With Cancer
22 Nov 2008 at 12:56am
family and friends are praying new treatments now coming out will increase those chances by 10 or 20 percent. His grandmother, friends and family are planning a benefit at the

Lung Cancer pill
21 Nov 2008 at 10:54pm
Houston (US), November 22: Iressa, the lung cancer pill, has shown surprising results for patients with advanced lung cancer where it has been at least as effective as a standard chemotherapy treatmen...

UH names interim director for cancer research center
21 Nov 2008 at 10:49pm
The University of Hawaii Board of Regents has appointed Michele Carbone as the new interim director of the Cancer Research Center of Hawaii. Carbone, a researcher with the center and chairman of the ...

Man Says His Dog Detected His Skin Cancer
21 Nov 2008 at 8:19pm
0 posts A man from Banbury near Oxford, England, said his dog sniffed out his skin cancer, reminiscent of reports of trials that have shown dogs can detect cancer, in some cases even when screening t...

Isolated Breast Cancer Cells In Sentinel Lymph Node Associated With Non-Senti...
21 Nov 2008 at 7:40pm
— Women who are found to have isolated breast cancer cells upon sentinel lymph node biopsy have a risk of having metastases in other lymph nodes.

Widely Used Cancer Drug Associated With Significantly Increased Risk Of Blood...
21 Nov 2008 at 7:40pm
— An analysis of randomized controlled trials indicates that use of the cancer drug bevacizumab is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of th...

Calcium Plus Vitamin D Supplementation Is Not Associated With A Reduced Breas...
21 Nov 2008 at 7:40pm
— Taking calcium and vitamin D supplements does not reduce breast cancer incidence in postmenopausal women, according to data from a randomized, doubled-blind, placebo-controlled trial published ...

Vic police embark on trek for cancer research
21 Nov 2008 at 7:14pm
A group of Victorian police officers will start a 350-kilometre trek today to raise money for cancer research and treatment. The 16 officers will walk and cycle 350 kilometres from Wodonga to Melbour...

Panama joins Laura Bush
21 Nov 2008 at 5:25pm
PANAMA CITY, Panama -- Laura Bush is applauding Panama's decision to join to a regional alliance for breast cancer awareness and research.The first lady says lives are being saved by the alliance, wh...

The nice cancer bloggers
21 Nov 2008 at 1:20pm
Do I just walk up to her and start talking - tell her that I have cancer too? Would I be invading her privacy? What if she's never talked to anyone her age with cancer and would be grateful to connect...

Cancer deaths higher in Britain than EU
21 Nov 2008 at 1:21pm
Posted on: Friday, 21 November 2008, 12:06 CST A British study suggests as many as 11,000 people in Britain die of unnecessarily of cancer each year because it takes too long for them to be diagnos...

Renowned presidential campaign duo headline m. d. anderson fundraiser
by M. D. Anderson Cancer Center - News Releases
21 Nov 2008 at 5:33am
In the wake of the nation's historic presidential election, political commentators Mary Matalin and James Carville will put aside their party differences Dec. 9 in Houston to raise funds for cancer research and patient care programs at The University of Texas M. D. Anderson Cancer Center. Matalin and Carville will be interviewed by veteran ABC News correspondent Sam Donaldson at "A Conversation With a Living Legend" from 11:30 a.m. - 1:30 p.m. at the Hilton Americas Hotel. The program will be emceed by former Houston news anchor Shara Fryer. The event already has raised more than $350,000 this year. (Source: M. D. Anderson Cancer Center - News Releases)

 

MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.



Qol of prostate cancer patients not accurately assessed by the fact-p
by MedWire News - Prostate Cancer
21 Nov 2008 at 4:01am
Patients with prostate cancer have numerous quality of life concerns that are inadequately assessed by standard health-related questionnaires such as the Functional Assessment of Cancer Therapy—Prostate questionnaire, UK researchers report. (Source: MedWire News - Prostate Cancer)

Hypertension and proteinuria: a class-effect of antiangiogenic therapies.
by Anti-Cancer Drugs
21 Nov 2008 at 1:13am
Page: 81DOI: 10.1097/CAD.0b013e3283161012Authors: Launay-Vacher, Vincent; Deray, Gilbert (Source: Anti-Cancer Drugs)

The spectrum of 5-fluorouracil cardiotoxicity.
by Anti-Cancer Drugs
21 Nov 2008 at 1:13am
Page: 79DOI: 10.1097/CAD.0b013e3283165f27Authors: Dalzell, Jonathan R. a; Samuel, Leslie M. b (Source: Anti-Cancer Drugs)

Alpha-fetoprotein expressing metastastic adenocarcinoma of the esophago-gastr...
by Anti-Cancer Drugs
21 Nov 2008 at 1:13am
Page: 75DOI: 10.1097/CAD.0b013e328312659aAuthors: Kripp, Melanie a; Strobel, Philipp b; Dinter, Dietmar c; Lukan, Nadine a; Hochhaus, Andreas a; Hofheinz, Ralf-Dieter a (Source: Anti-Cancer Drugs)

 

MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.



Long-term disease stabilization during second-line gemcitabine in a refractor...
by Anti-Cancer Drugs
21 Nov 2008 at 1:13am
Page: 73DOI: 10.1097/CAD.0b013e32831b9b0bAuthors: Pintoffl, Jan a; Meisinger, Ines a; Mayer, Frank a; Horger, Marius b d; Weyhern, Claus von c; Kanz, Lothar a; Hartmann, Joerg Thomas a d (Source: Anti-Cancer Drugs)

Rhein lysinate suppresses the growth of breast cancer cells and potentiates t...
by Anti-Cancer Drugs
21 Nov 2008 at 1:13am
Page: 65DOI: 10.1097/CAD.0b013e3283182913Authors: Lin, Ya-Jun; Zhen, Yong-Su (Source: Anti-Cancer Drugs)

Pi3k/akt is involved in bufalin-induced apoptosis in gastric cancer cells.
by Anti-Cancer Drugs
21 Nov 2008 at 1:13am
Page: 59DOI: 10.1097/CAD.0b013e3283160fd6Authors: Li, Dan *; Qu, Xiujuan *; Hou, Kezuo; Zhang, Ye; Dong, Qian; Teng, Yuee; Zhang, Jingdong; Liu, Yunpeng (Source: Anti-Cancer Drugs)

Gene expression changes during the development of estrogen-independent and an...
by Anti-Cancer Drugs
21 Nov 2008 at 1:13am
Page: 51DOI: 10.1097/CAD.0b013e32831845e1Authors: Pennanen, Pasi T. a; Sarvilinna, Nanna S. a; Ylikomi, Timo J. a b (Source: Anti-Cancer Drugs)

Enediyne lidamycin enhances the effect of epidermal growth factor receptor ty...
by Anti-Cancer Drugs
21 Nov 2008 at 1:13am
Page: 41DOI: 10.1097/CAD.0b013e328318292cAuthors: Liu, Hong; Li, Liang; Li, Xing-Qi; Liu, Xiu-Jun; Zhen, Yong-Su (Source: Anti-Cancer Drugs)

 

MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.



Coenzyme q0 induces apoptosis and modulates the cell cycle in estrogen recept...
by Anti-Cancer Drugs
21 Nov 2008 at 1:13am
Page: 33DOI: 10.1097/CAD.0b013e328314b5c5Authors: Somers-Edgar, Tiffany J.; Rosengren, Rhonda J. (Source: Anti-Cancer Drugs)

The metal-binding domain of igfbp-3 selectively delivers therapeutic molecule...
by Anti-Cancer Drugs
21 Nov 2008 at 1:13am
Page: 21DOI: 10.1097/CAD.0b013e3283144610Authors: Huq, Anja a b; Singh, Baljit a b; Meeker, Thea b; Mascarenhas, Desmond a b (Source: Anti-Cancer Drugs)

Long-term response to pegylated liposomal doxorubicin in patients with metast...
by Anti-Cancer Drugs
21 Nov 2008 at 1:13am
Page: 15DOI: 10.1097/CAD.0b013e3283198058Authors: Grenader, Tal a; Goldberg, Anthony a; Hadas-Halperin, Irit b; Gabizon, Alberto a (Source: Anti-Cancer Drugs)

Thioguanine pharmacokinetics in induction therapy of children with acute myel...
by Anti-Cancer Drugs
21 Nov 2008 at 1:13am
Page: 7DOI: 10.1097/CAD.0b013e32831bc086Authors: Josefine, Palle a; Britt-Marie, Frost a; Curt, Petersson b; Henrik, Hasle c; Marit, Hellebostad e; Jukka, Kanerva f; Kjeld, Schmiegelow d; Gudmar, Lonnerholm a; on behalf of the Nordic Society for Paediatric Haematology and Oncology (Source: Anti-Cancer Drugs)

Inhibition of hepatocelluar carcinoma mat2a and mat2betagene expressions by s...
by Journal of Experimental and Clinical Cancer Research
20 Nov 2008 at 10:00pm
In this study, for the first time we established a dual small interfering RNA (siRNA) expression system, which could simultaneously express two different siRNA molecules specifically targeting two genes. To test the effectiveness of this system, we applied this approach to express simultaneously two different siRNA duplexes that specifically target MAT2A and MAT2betagenes of hepatocelluar carcinoma respectively in HepG2 cell. Results indicated that dual siRNA could simultaneously inhibit the expression of MAT2A and MAT2betagene by 89.5% and 97.8% respectively, In addition, dual siRNA molecules were able to significantly suppress growth of hepatocelluar carcinoma cell in vitro as well as induce apoptosis which was involved in arrest cell cycle at the G1/ S checkpoint and the expressions of ...

 

MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.



Study ties saturated fat to small intestine cancer
21 Nov 2008 at 5:33pm
Diets high in saturated fat appear to increase the risk of cancer of the small intestine, a study shows.

Pill as good as chemo against lung cancer
20 Nov 2008 at 6:09pm
Some advanced lung cancer patients already treated with chemotherapy might be able to skip some of the bad side effects of another series of chemo by taking a pill instead.

Family history can trump breast cancer test
17 Nov 2008 at 10:53am
If breast cancer runs in the family, women can be at high risk even if they test free of the disease's most common gene mutations, sobering new research shows.

Sacs released by tumors may help defeat cancer
17 Nov 2008 at 4:35pm
Tiny sacs released from tumor cells and circulating in the blood carry genetic information about the tumor, offering a new way to track and treat the cancer, U.S. researchers said.

Vitamins C and E fail to prevent cancer
16 Nov 2008 at 12:56pm
Men who took vitamin C or E supplements were no more or less likely to develop cancer than those given a placebo, indicating the antioxidants don't prevent the disease, researchers said.

Genetic clues may explain why tumors spread
13 Nov 2008 at 5:42pm
A small fragment of genetic material may mean the difference between an easily treated local tumor and an aggressive cancer that spreads throughout the body, researchers said.

Four drug combination helps fight lung cancer
13 Nov 2008 at 12:03pm

Nov. 13: TODAY’s Matt Lauer tells the story of his friend John Atkinson’s battle with lung cancer; NBC’s chief medical editor Dr. Nancy Snyderman discusses the disease. (Today Show)Combining two chemotherapy drugs with two targeted therapies was safe and appeared to help patients with advanced lung cancer live longer, U.S. researchers reported on Thursday.




HPV vaccine can prevent genital warts in men
13 Nov 2008 at 12:28pm
For the first time, an expensive vaccine aimed at preventing cervical cancer in women has proven successful at preventing a disease in men, according to a new study.

Key 'switch' found for breast cancer drug
12 Nov 2008 at 12:23pm
Scientists have pinpointed the molecular on-off switch that the powerful drug tamoxifen uses to attack breast cancer and which prevents it from working in some women.

Migraines cut breast cancer risk 30 percent
6 Nov 2008 at 10:07am
In a puzzling twist, women who have a history of migraine headaches are far less likely to develop breast cancer than other women, U.S. researchers said on Thursday.

Genome of cancer patient decoded for first time
5 Nov 2008 at 4:44pm
Scientists for the first time have decoded the entire genome of a cancer patient, identifying a series of genes never before linked to a type of white blood cell cancer.

Vitamin B supplements no help against cancer
5 Nov 2008 at 10:26am
Vitamin B supplements do not appear to protect against cancer as some previous research had suggested, according to a U.S. study.

HPV linked to 25,000 cancers in 5 years
3 Nov 2008 at 11:57am
HPV caused 25,000 cases of cancer in the U.S. between 1998 and 2003, including not only cervical cancer but also anal and mouth cancers, the CDC reported on Monday.

Two lung cancer genes identified
2 Nov 2008 at 2:01pm
An international research team has identified two genetic variations that appear to increase a person's risk of developing lung cancer by up to 60 percent.

Hot flushes linked to breast cancer drug success
30 Oct 2008 at 10:16am
Hot flushes, night sweats or painful joints may be good news for women taking hormone-based drugs for breast cancer — it may mean their tumors are less likely to return, researchers said on Thursday.

Man Says His Dog Detected His Skin Cancer
21 Nov 2008 at 1:00pm
A man from Banbury near Oxford, England, said his dog sniffed out his skin cancer, reminiscent of reports of trials that have shown dogs can detect cancer, in some cases even when screening tests can't. Chris Tuffrey told the BBC yesterday that his pet Rottweiler, called Beamish, kept nuzzling and licking him and trying to get him to lift his arm.

Scientists Honored For Contributions To Cancer Fight
21 Nov 2008 at 7:00am
The American Cancer Society - the nation's leading voluntary health organization and largest non-governmental funder of cancer research and discovery - will present its highest honor, the Medal of Honor, to four Americans who have made outstanding contributions to the fight against cancer. This year's winners, who will receive their awards at a ceremony during the American Cancer Society's annual meeting in New York City, are: The Honorable Edward M.

Tumor Formation May Be Spurred By The Misreading Of Damaged DNA
21 Nov 2008 at 6:00am
The DNA in our cells is constantly under assault from oxygen, the sun's radiation and environmental stresses. Most of the time, our cells can repair the damage before it gets copied into a permanent mutation that could lead to cancer. Adding a wrinkle to our understanding of how cancers begin, scientists have found that cells can turn on tumor-promoting growth circuits as a result of misreading damaged DNA without copying it: a process called "transcriptional mutagenesis.

Tumors Fuelled By Lactic Acid
21 Nov 2008 at 6:00am
A team of researchers at Duke University Medical Center and the Université catholique de Louvain (UCL) has found that lactic acid is an important energy source for tumor cells. In further experiments, they discovered a new way to destroy the most hard-to-kill, dangerous tumor cells by preventing them from delivering lactic acid.

Survival Of Melanoma Cells Promoted By Gene Required For Radiation-Induced Pr...
21 Nov 2008 at 5:00am
Scientists have new insight into the response of human skin to radiation and what drives the most aggressive and deadly form of skin cancer. The research, published by Cell Press in the November 21st issue of the journal Molecular Cell, may be useful in the design of new strategies for prevention of malignant melanoma. The process of tanning involves synthesis of the pigment melanin by skin cells known as melanocytes.

Oral Gefitinib As Effective As Injected Docetaxel For Survival Of Patients Wi...
21 Nov 2008 at 4:00am
Gefitnib is as effective a second-line treatment as docetaxel for patients with non-small cell* lung cancer. The INTEREST study, published in an Article in this week's edition of The Lancet, thus establishes gefitinib as a valid treatment option for people with this condition. The study was written by Dr Edward Kim, M. D. Anderson Cancer Center, Houston, Texas, USA and colleagues.

Type Of Breast Reconstruction Impacts Radiation Therapy Outcomes
21 Nov 2008 at 3:00am
For breast cancer patients who underwent a mastectomy who undergo radiation therapy after immediate breast reconstruction, autologous tissue reconstruction provides fewer long-term complications and better cosmetic results than tissue expander and implant reconstruction, according to a study in the November issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.

Ortho Biotech Announces NDA Submission For Trabectedin For The Treatment Of R...
21 Nov 2008 at 2:00am
Ortho Biotech Products, L.P. announced the submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for trabectedin when administered in combination with DOXIL(R) (doxorubicin HCI liposome injection)for the treatment of women with relapsed ovarian cancer (ROC). If approved, trabectedin combined with DOXIL will provide a new, non-platinum treatment option for these patients in the United States.

Pediatric Cancer : Alteration Of A Gene Causes Neuroblastoma
21 Nov 2008 at 2:00am
Olivier Delattre's team (Inserm Unit 830 "Genetics and Biology of Cancer") of the Institut Curie reveal in an article in the 16 October issue of Nature that alteration of the ALK gene is closely associated with the most frequent solid extracerebral tumor in children neuroblastoma. By studying the familial forms of this tumor, the researchers also conclude that ALK is a gene that predisposes to neuroblastoma. This discovery may allow the development of new treatments in neuroblastomas.

Bovie Medical Corporation Announces FDA 510(K) Clearance To Market SEER Tissu...
20 Nov 2008 at 11:00am
Bovie Medical Corporation (the "Company") (NYSE Alternext US: BVX), a manufacturer and marketer of electrosurgical products, today announced the Company received 510(k) clearance from the Food and Drug Administration (FDA) to market its SEER tissue resection device intended for initial use in liver oncology surgery. The SEER device uses conductive sintered steel as an electrode for radio frequency (RF) for cutting and coagulation.

Randomized Phase 2 Study Of IMC-A12 For HER2-Expressing Advanced Breast Cance...
20 Nov 2008 at 11:00am
ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that its disease-directed randomized Phase 2 clinical trial of IMC-A12 in patients with previously treated HER2-expressing locally advanced or metastatic breast cancer has commenced patient enrollment. IMC-A12 is ImClone's fully human, IgG1 anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody.

GenVec Announces Interim Survival Data In Pivotal Trial Of TNFeradeâ„¢ In Local...
20 Nov 2008 at 11:00am
GenVec, Inc. (Nasdaq:GNVC) announced today top-line results of an interim analysis from its ongoing Phase III Pancreatic Cancer Clinical Trial with TNFeradeâ„¢ (PACT) in patients with locally advanced pancreatic cancer. This interim analysis of overall survival, conducted after the 92nd death (one-third of total expected events), was designed to determine whether the study should continue and took place in the time frame originally estimated.

Relapsed Ovarian Cancer - Submitted New Drug Application To FDA For Trabectedin
20 Nov 2008 at 10:00am
PharmaMar announced today that Ortho Biotech Products, L.P. has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for trabectedin when administered in combination with DOXIL® (pegylated liposomal doxorubicin) for the treatment of women with relapsed ovarian cancer (ROC). If approved, trabectedin combined with DOXIL® will provide a new, non-platinum treatment option for these patients in the United States.

Higher Risk Of Certain Cancers Being Recorded In HIV-Positive People
20 Nov 2008 at 9:00am
Physicians in the U.S. are reporting a higher risk for certain types of cancers -- such as liver, head, neck and lung -- in people living with HIV/AIDS, raising concerns that a cancer epidemic is imminent in the population, the Baltimore Sun reports. According to the Sun, Meredith Shiels, a doctoral candidate at the

Ovarian Cancer Cells Destroyed By New Platinum-Phosphate Compounds
20 Nov 2008 at 8:00am
A new class of compounds called phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than conventional drugs, according to a new study published this week in the journal Proceedings of the National Academy of Sciences.

   Site Map
All information in this site is deemed reliable but not guaranteed. Garypedia.com web site owner shall not be responsible for any typographical errors, misinformation, and misprints and shall be held totally harmless individually.Garypedia.com is an independent provider of links to news articles. Garypedia.com contains links to sites on the internet which are owned and operated by the "External Sites". Garypedia.com is not responsible for the availability of any External Sites. Contact the site administrator or Webmaster for those External Sites if you have any concerns regarding such links or the links located on such External Sites. Garypedia.com is entirely committed to protecting the privacy of its mediapartners and their users. We use a browser feature known as a cookie. One way our cookies are useful is that they help to improve and personalize your experience by increasing a page's responsiveness and decreasing time between downloading as you browse or surf through the site. Additionally, a pixel tag is delivered with the newsfeeds themselves to organize information about online activity as a means to create anonymous profiles that reflect content preferences. No personally identifiable information is stored or collected. Any suggestions, please email us.
Copyright © 2007 Garypedia.com. All rights reserved.